[Object] In the case of using 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, or methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate as a medicine, more preferable aspects or improved methods are provided. [Means] Crystals of any compound among 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, and methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate, and methods of producing the same are provided.(과제)3-[3-아미노-4-(인단-2-일옥시)-5-(1-메틸-1H-인다졸-5-일)페닐]프로피온산, 3-[4-(인단-2-일옥시)-3-(1-메틸-1H-인다졸-5-일)-5-니트로페닐]프로피온산메틸, 또는 3-[3-아미노-4-(인단-2-일옥시)-5-(1-메틸-1H-인다졸-5-일)페닐]프로피온산메틸을 의약으로서 사용함에 있어서, 보다 바람직한 형태나 개선된 방법을 제공한다.(해결수단)3-[3-아미노-4-(인단-2-일옥시)-5-(1-메틸-1H-인다졸-5-일)페닐]프로피온산, 3-[4-(인단-2-일옥시)-3-(1-메틸-1H-인다졸-5-일)-5-니트로페닐]프로피온산메틸, 또는 3-[3-아미노-4-(인단-2-일옥시)-5-(1-메틸-1H-인다졸-5-일)페닐]프로피온산메틸 중 어느 하나의 화합물의 결정 및 제조 방법이 제공된다.
